Severe cases of COVID-19 disease exhibit a range of immunological, kidney, liver and heart complications that require laboratory investigation. Randox Laboratories provides an overview and looks at quality control and assessment of testing.
The SARS-CoV-2 strain of coronavirus, which can lead to COVID-19 disease, presents in many as a minor cold or influenza; however, for those with health complications, including autoimmune diseases, asthma, heart disease and diabetes, the risk of developing serious illness and adverse outcomes is much greater.
Currently, it is estimated that as many as one in six will experience complications that could be life-threatening.1 Because of the spread and devastation of COVID-19, laboratory diagnostics plays an even more important role in the diagnosis and management of suspected cases or affected patients.
As the spread and devastation of the SARS-CoV-2 pandemic continues to grow, it is vital that fast and accurate diagnostic testing strategies are implemented for effective risk stratification, monitoring of treatment and recovery.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.